Weiss, B., Plotkin, S., Widemann, B., Tonsgard, J., Blakeley, J., Allen, J., . . . Fisher, M. (2018). NFM-06. NF106: PHASE 2 TRIAL OF THE MEK INHIBITOR PD-0325901 IN ADOLESCENTS AND ADULTS WITH NF1-RELATED PLEXIFORM NEUROFIBROMAS: AN NF CLINICAL TRIALS CONSORTIUM STUDY. Neuro Oncol.
Citação norma ChicagoWeiss, Brian, et al. "NFM-06. NF106: PHASE 2 TRIAL OF THE MEK INHIBITOR PD-0325901 IN ADOLESCENTS AND ADULTS WITH NF1-RELATED PLEXIFORM NEUROFIBROMAS: AN NF CLINICAL TRIALS CONSORTIUM STUDY." Neuro Oncol 2018.
Citação norma MLAWeiss, Brian, et al. "NFM-06. NF106: PHASE 2 TRIAL OF THE MEK INHIBITOR PD-0325901 IN ADOLESCENTS AND ADULTS WITH NF1-RELATED PLEXIFORM NEUROFIBROMAS: AN NF CLINICAL TRIALS CONSORTIUM STUDY." Neuro Oncol 2018.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.